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Table 1
Gene/Isoform expression summary
Genes
Normal OA
Total Genes Expressed 14,531 15,218
Normal Only 24
OA Only 107
Up-regulated (2-fold or greater
difference, q < 0.05)
415
Down-regulated (2-fold or greater
difference, q < 0.05)
447
Known Isoforms
Normal OA
Total Known Isoforms Expressed 30,051 31,196
Normal Only 137
OA Only 296
Up-regulated (2-fold or greater
difference, q < 0.05)
71
Down-regulated (2-fold or greater
difference, q < 0.05)
83
Table 2
MicroRNA expression levels and log2 (Fold Change) in normal and OA cartilage
Name Normal FPKM OA FPKM log2 (Fold Change) q value
hsa-mir-21 132473 1252710 3.2 0.002
hsa-let-7f-2 10160 91408 3.2 0.011
hsa-mir-142 0 1063 3.0 0.032
hsa-mir-374a 0 2807 3.0 0.009
hsa-mir-1299 0 3965 3.0 0.002
hsa-mir-4318 0 1860 3.0 0.014
hsa-mir-676 0 5108 3.0 0.013
hsa-mir-4510 0 3017 3.0 0.011
hsa-mir-1269b 0 2066 3.0 0.020
hsa-mir-4662a 0 127 3.0 0.027
hsa-mir-146b 163032 1047150 2.7 0.002
hsa-kd-7f-L 3522 20550 2.5 0.044
hsa-mir-100 2612720 14731500 2.5 0.010
hsa-mir-98 9525 48702 2.4 0.011
hsa-mir-155 48783 222402 2.2 0.022
hsa-mir-10b 6266400 26510400 2.1 0.028
hsa-mir-196a-2 18856 78934 2.1 0.016
hsa-mir-195 82217 339757 2.0 0.004
hsa-mir-130a 24770 102014 2.0 0.016
hsa-Iet-7e 115006 400877 1.8 0.013
hsa-mir-125a 1339370 4645820 1.8 0.023
hsa-mir-26b 389707 1160830 1.6 0.030
hsa-mir-7846 680920 221645 -1.6 0.049
hsa-mir-7108 631835 183699 -1.8 0.023
hsa-mir-4792 1374620 398265 -1.8 0.018
hsa-mir-4734 2789150 796241 -1.8 0.027
hsa-mir-8069 271520 73374 -1.9 0.049
hsa-mir-4767 1438000 384786 -1.9 0.036
hsa-mir-3195 3665880 888282 -2.0 0.004
hsa-mir-4651 1435880 341355 -2.1 0.014
hsa-mir-6814 312896 61907 -2.3 0.013
hsa-mir-1302-1 18718 3102 -2.6 0.014
hsa-mir-614 159705 24408 -2.7 0.017
hsa-mir-4762 59921 8291 -2.9 0.038
hsa-mir-581 1487 0 -3.0 0.002
hsa-mir-4427 2721 0 -3.0 0.015
hsa-mir-4445 4331 0 -3.0 0.002
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INTEGRATIVE OMICS PROFILING OF OSTEOARTHRITIS
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Purpose: Osteoarthritis (OA) is a prevalent joint disease that is char-
acterized by the destruction of articular cartilage, although the disease
process affects all joint tissues. Understanding the biology of joint
homeostasis and the mechanisms of disease will increase our under-
standing of OA, particularly as it relates to aging. This long-term study
aims to integrate genomic, epigenetic, transcriptomic and proteomic
data on both normal and OA joint tissues to build a multidimensional
molecular proﬁle for OA and aging. The ﬁrst phase of this project
explores the gene expression proﬁles of articular cartilage from normal
and OA human knee joints. In this study, we used RNA-sequencing
(RNA-seq) to characterize gene expression proﬁles, to identify non-
coding RNA species and to discover key biological pathways that are
dysregulated in OA.
Methods: We extracted total RNA from full-thickness articular carti-
lage from 20 human donors (10 normal and 10 severe OA) using the
Ambion RNAqueous Kit and prepared RNA libraries for sequencing
using the NuGen Encore Complete RNA-Seq DR Multiplex System. We
used the miRNeasy Mini Kit to purify small RNA from the same donors
and prepared the libraries with the Illumina TruSeq small RNA sample
prep kit. Sequencing was performed on an Illumina HiSeq 2000 (sin-
gle-end, 100 bp reads). The reads were trimmed for adapters using
CUTADAPT, and the small RNA reads were ﬁltered for lengths ranging
from 15-35 nucleotides with a custom Python script. Trimmed and raw
data were checked for quality using FASTQC, and the raw fastq ﬁles
were aligned to the human genome (hg19) using TOPHAT2. Aligned
transcripts were assembled with CUFFLINKS2 and differentially
expressed (DE) transcripts were determined using CUFFDIFF2 with a q-
value less than 0.05, fragment bias correction and upper quartile
normalization. Non-coding RNA species were quantiﬁed using HTSEQ-
COUNT with annotations from NONCODE (Version 4), miRBase
(Release 20) and piRNABank for long non-coding RNA (lncRNA),
microRNA (miRNA) and piwi-interacting RNA (piRNA), respectively.
We conducted a signaling pathway impact analysis using the Bio-
conductor packages SPIA and Graphite with the KEGG, Reactome,
BioCarta and National Cancer Institute/Nature Pathway Interaction
Databases (NCI/NPID) to identify potential functional pathways dys-
regulated in OA.
Results: A total of 862 genes were DE between OA and normal human
cartilage (Table 1). One thousand four hundred and thirty miRNAs
were expressed in normal cartilage and 1,665 miRNAs were
expressed in OA cartilage. Of these expressed miRNAs, 257 were only
expressed in OA cartilage, 22 were only expressed in normal cartilage
and 37 unique miRNAs were DE (Table 2). Analysis of piRNAs revealed
150 unique piRNAs expressed in OA, 37 of which are DE (q < 0.05). A
total of 8,642 lncRNAs were expressed in OA articular cartilage and 8
were DE between OA and Normal. Signaling pathway impact analysis
revealed 10 signiﬁcantly perturbed pathways in OA (Table 3)
Conclusions: This integrated Omics proﬁle of OA articular cartilage
reveals complex gene expression patterns, potential gene regulatory
mechanisms through non-coding RNAs and dysregulated pathways that
are involved in the disease. These results provide insights into an
integrated, molecular understanding of OA.Genes and known isoforms expressed in normal and OA articular
cartilage.
Expression determined by CuftDiff2, after Benjamini-Hochberg cor-
rection. The fold change is the ratio of OA FPKM to normal FPKM.
Table 3
Signiﬁcantly dysregulated pathways in OA
Rank Name pSize NDK pNDE tA pPERT pG pGFdr pGFWER Status
1 PI3K Akt signaling pathway 337 21 2.96E-08 -5.30E+01 1.20E-02 8.09E-09 7.93E-07 7.93E-07 Inhibited
2 Circadian rhythm 30 7 2.04E-07 -7.24E+00 5.00E-02 1.98E-07 9.70E-06 1.94E-05 Inhibited
3 HIF-1-alpha transcription factor network 63 10 2.50E-08 1.55E+00 6.68E-01 3.16E-07 3.59E-05 4.49E-05 Activated
4 Validated transcriptional targets of
AP1 family members Fra1 and Fra2
37 7 9.46E-07 6.56E+00 2.90E-02 5.05E-07 3.59E-05 7.17E-05 Activated
5 HIF-1 signaling pathway 108 11 5.39E-07 1.13E+01 3.86E-01 3.41E-06 1.11E-04 5.34E-04 Activated
6 C-MYB transcription factor network 77 10 1.79E-07 1.03E+00 8.88E-01 2.65E-06 1.26E-04 3.77E-04 Activated
7 Acute myeloid leukemia 56 7 1.68E-05 2.28E+00 6.82E-01 1.42E-04 2.79E-03 1.39E-02 Activated
8 ECM-receptor interaction 86 6 1.64E-03 -1.34E+01 7.00E-01 1.42F-04 2.79E-03 1.40E-02 Inhibited
9 IL6-mediated signaling events 47 6 6.04E-05 7.06E+00 3.84E-01 2.71E-04 9.61E-03 3.85E-02 Activated
10 HTLV-I infection 260 13 1.28E-04 -8.73E+00 2.93E-01 4.20E-04 1.19E-02 4.74E-02 Inhibited
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S232pSize: number of genes in the pathway; NDE: number of DE genes in
pathway; pNDE: Probability to observe at least NDE genes in the
pathway; tA: observed total perturbation accumulation in the pathway;
pPERT: probability to observe a total accumulation more extreme than
tA by chance; pG: p-value obtained by combinging pNDE and pPERT;
pGFdr: False discovery rate; pGFWER: Bonferroni adjusted global p-
values; Status: Direction in which the pathway is perturbed.
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POWERFUL DETECTION OF OSTEOARTHRITIS SUSCEPTIBILITY LOCI
BY COMPREHENSIVE EXAMINATION OF CLINICALLY IMPORTANT
ENDOPHENOTYPES
K. Panoutsopoulou y, S. Thiagarajah z, A. Day-Williams y, L. Southam y,
K. Hatzikotoulas y, A. Matchan y, M. Doherty x, J.M. Wilkinson z,
E. Zeggini y. arcOGEN Consortium; yWellcome Trust Sanger Inst.,
Hinxton, United Kingdom; zAcademic Unit of Bone Metabolism, Dept. of
Human Metabolism, Univ. of Shefﬁeld, Shefﬁeld, United Kingdom;
xAcademic Rheumatology, Nottingham City Hosp., Nottingham, United
Kingdom
Purpose: Osteoarthritis (OA) is a highly heterogeneous disease char-
acterised by variable clinical features with possibly different genetic
aetiologies. Thus far, the few genetic variants that have been robustly
associated with broad deﬁnitions of OA (n ¼ 13 in Europeans) explain
only a small proportion of its heritability. Our aim is to identify novel OA
susceptibility variants by examining an expanded set of more homo-
geneous, radiographically-derived OA endophenotypes relating to joint
morphology, speciﬁc anatomic pattern of joint involvement, severity
and bone response in OA.
Methods: 2,000 knee and 2,000 hip OA cases with radiographs have
been genotyped as part of the arcOGEN study on the Illumina Human
610-Quad Beadchip and Illumina HumanOmniExpress Beadchip arrays.
Variables relating to joint morphology, speciﬁc anatomic pattern of joint
involvement, severity and bone responses in OA were extracted from
digitised radiographs. Following 1000 Genomes Project-based imputa-
tion and stringent quality control >7 million variants were tested for
associationwith each phenotype. Logistic regressionwas used for binary
variables and linear regression was used for continuous variables
adjusted for gender. Fixed-effects meta-analysis was used to combine
the results from the two genome-wide association studies (GWAS).
Results: Our results indicate that the study of endophenotypes in OA
has the potential to dramatically enhance power to detect OA-relevant
associations. For example analysis by knee compartment involvement
vs population-based controls yielded 25 independent loci for knee OA
at p < 1 106 in contrast to 1 locus detected for knee OA vs controls in
the equivalent binary trait GWAS. In hip OA endophenotype analyses
several promising signals were identiﬁed some of which are found near
genes that are very plausible biological candidates for OA. For example
in the analysis of atrophic vs hypertrophic hip OA response a strong
signal (OR [95% CI] ¼ 2.03 [1.57–2.63], p ¼ 2.5  108) was detected in
the G protein-coupled receptor, GPR98. Polymorphisms in GPR98 and
another G protein-coupled receptor (GPR48) have been associated with
osteoporotic fracture and low bone mineral density respectively and
gpr98 knockout mice have a low bone mass phenotype. Pattern of hip
migration (axial/medial vs non-axial/medial migration) shows strong
association with variants in LRCH1 (rs754106, p¼2.9x10-7) previously
suggestively associated with OA and BMP1 (chr8: 22065846, p ¼ 2.6 
107) which induces bone and cartilage development. From the hipmorphology studies the strongest signals were detected in the analysis
of femoral neck-length-to-width ratio (rs3112954, located in an intron
of ZNF385B, p¼ 6.5108 and rs11695150, p¼ 8.8 108 located in an
intron of PP1R21).
Conclusions: Through a comprehensive examination of radio-
graphically-derived, OA-related phenotypes we have identiﬁed several
promising signals that point to novel and biologically plausible genes
for OA. Our results indicate that, in a heterogeneous disease like OA the
study of narrower phenotype deﬁnitions closer to the biology of the
disease has the potential to dramatically enhance power to detect OA-
relevant associations and yield an unprecedented amount of informa-
tion on OA susceptibility genes. Further replication is required to boost
power and validate these associations.
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NEW FUNCTIONAL MICROSATELLITE ASSOCIATED WITH
OSTEOARTHRITIS SUSCEPTIBILITY
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Purpose: Considering that two functional microsatellites are associated
with OA, in the BMP5 and ASPN genes, and that their effects are poorly
represented by neighboring SNPs, we hypothesized that other genetic
variants with these characteristics could contribute to OA susceptibility
and have escaped detection in GWAS. To test this hypothesis we
searched the bibliography identifying six additional functional micro-
satellites. Two had been already associated with OA in studies with less
than 150 patients, in the interleukin (IL10) and calcitonin (CA) genes,
whereas a second microsatellite in IL10 was studied, but did not show
association. Three other functional microsatellites, in the estrogen
receptor 2 (ESR2), the tyroxine hydroxylase (TH) and the macrophage
migration inhibitory factor (MIF) genes, have never been studied in OA.
We analyzed these six microsatellites in a large case-control study.
Methods: The six functional microsatellites were ampliﬁed with
labeled primers in samples from 3557 patients with OA (1775 of knee
OA and 1782 of hip OA) and in 1878 healthy controls of similar age. All
patients and controls were of European Caucasian ancestry either from
the UK, Greece or Spain. A subset of samples was genotyped twice for
quality control. POWERMARKER, CLUMP and GENEPOP were used for
analysis. Genotypes of SNPs in the neighborhood of the BMP5, ASPN,MIF
and TH microsatellites were obtained from the arcOGEN GWAS for the
UK samples included in this study. They were used to assess imputation
of microsatellite genotypes with the Beagle and IMPUTE algorithms.
Results: Genotypes of the CA microsatellite were inconsistent in repli-
cation and discarded. Reproducible genotypes were obtained for the
other ﬁve microsatellites with call rates >0.93. The MIF microsatellite
showed ﬁve alleles (from 4 to 8 repeats) with homogeneous frequency
distribution in the three populations. This microsatellite was associated
with hip OA with contrasting effects in women (P of the Mantel-
Haenszel analysis ¼ 0.018) and men (PM-H ¼ 0.029): the 6 repeat allele
